The Food and Drug Administration, which had initially rejected the application, finally gave the company the green light
Neuralink, Elon Musk’s brain-implant company, said on Thursday it had received a green light from the US Food and Drug Administration (FDA) to kickstart its first in-human clinical study, a critical milestone after earlier struggles to gain approval.
Musk has predicted on at least four occasions since 2019 that his medical device company would begin human trials for a brain implant to treat severe conditions such as paralysis and blindness.
About Author
More Stories
Exercise ‘better than drugs’ to stop cancer returning after treatment, trial finds
Cancer experts warn of coffee enemas and juice diets amid rise in misinformation
Elon Musk shows he still has the White House’s ear on Trump’s Middle East trip